Dynarex Corporation recalled 2,400 containers of Wecare Calasoothe on October 31, 2025, due to cGMP deviations. The recall affects the 4 oz ointment, as it may not meet safety standards. Consumers should stop using the product immediately and consult their healthcare providers.
cGMP deviations
Consumers and healthcare providers should stop using this product immediately. Contact Blossom Pharmaceuticals or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Wecare Calasoothe is a topical ointment containing menthol and zinc oxide. Consumers typically use it for soothing skin irritations and minor wounds.
The cGMP deviations may affect the product's quality and safety, potentially leading to ineffective treatment or adverse reactions.
This recall is not part of a broader industry pattern.
Consumers may face safety risks by using this product. Immediate action is necessary to prevent potential health issues.
Lot numbers can typically be found on the bottom or side of the container.
Expect processing for refunds or replacements to take approximately 4-6 weeks.
Keep copies of receipts, photographs of the product, and any communications with the manufacturer.
Wecare Calasoothe has a net weight of 4 oz (113 g) and is manufactured by Dynarex Corporation, located at 10 Glenshaw Street, Orangeburg, NY 10962. The product is identified by NDC 67777-234-04 and was distributed nationwide in the USA.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Dynarex Obstetrical Towelettes Cleanser is under an active FDA recall as of Jan. 20, 2026. The recall cites CGMP Deviations that could affect product quality. Consumers and healthcare providers should stop using the product immediately and contact ACME United Corporation or a healthcare provider for guidance.
Dynarex Corporation recalled 18,912 containers of Wecare Enema on October 31, 2025, due to cGMP deviations. Consumers should stop using the product immediately. The recall affects products distributed nationwide in the USA.
Dynashield, a 4 oz cream, is recalled after cGMP deviations were identified. The recall affects 7,944 units distributed nationwide. Consumers should stop using the product immediately and contact their healthcare provider for guidance.
Dyrnarex Corporation recalled 1,560 containers of Dynashield Skin Protectant on October 31, 2025. The product may not meet current Good Manufacturing Practice standards. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Dynarex Corporation recalled 2,592 bottles of WeCare Zinc Oxide Ointment on October 31, 2025, due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers and healthcare providers must stop using the ointment immediately and seek guidance.